Background/Aims: Enhance at puberty-1 (Eap1) is an intronless gene that regulates the onset of puberty through a network of hypothalamic genes. However, precise mechanistic events essential for Eap1-regulation of puberty have not been fully elucidated. Eap1 is thought to promote the initiation of puberty through regulation of the hypothalamic metastasissuppressor KiSS1. We aim to investigate this hypothesis by genetically perturbing Eap1 through RNA interference in vivo. Methods: We first engineered and optimized four sets of shRNAs that target rat Eap1 mRNA as well as one negative control shRNA. After generating lentiviral (LV) particles, we examined the suppression of Eap1 in NRK-54E cell line to select the most efficient one. Sequencelly, LV-Eap1-shRNA or controls including LV-eGFP and saline were intraventricular microinjected into 21-day-old rats. Rats were raised in appropriate conditions and we examined the time of vaginal opening, ovary physiology as well as hypothalamic puberty-regulatory genes at three developmental stages: juvenile (postnatal day PND25), early puberty (PND35), adult (PND42). Results: Hypothalamic suppression of Eap1 delayed the onset of rat vaginal opening. Hematoxylin and eosin (H&E) staining revealed a significant reduction of corpus luteum (CL) at PND35, but at PND42 CL levels were normal relative to control. In conjunction with differences in phenotype and ovary morphology, GnRH expression and transcripts were also reduced at PND25 and PND35, while their levels were similar to control at PND42. KiSS1 mRNA and protein levels were not significantly different at all three developmental stages. Conclusion: Eap1 expression critically regulates puberty as well as GnRH expression. However, Eap1-regulation of puberty may not necessitate KiSS1/ GPR54 signaling.
Introduction
The onset of puberty is regulated by the hypothalamic-pituitary-gonadal (HPG) axis, which is inactive during childhood. Activation of gonadotropin-releasing hormone (GnRH)-expressing neurons in the hypothalamus triggers the onset of puberty [1] . However, the exact molecular mechanism underlying sexual maturation in the brain remains poorly understood. In the past decades, several comprehensive studies have together revealed that hypothalamic control of puberty is not determined by a single gene. Instead, a sophisticated gene network in the hypothalamus controls this event hierarchically [2, 3] . In 2007, Heger et al. [4] . first identified patterns of increased C4ORF4 mRNA in the hypothalamus of nonhuman primates during puberty. Furthermore, they found that C4ORF4 played an important role in regulating the onset of puberty as well as maintenance of reproductive function. They subsequently renamed it enhanced at puberty-1 (Eap1) and numerous studies have since exmined this gene. However despite such efforts, the precise molecular mechanism of Eap1-regulation of puberty remains unclear. Matagneet et al. [5] . reported that Eap1 must be centrally regulated as they detect enhanced expression during puberty occurs even in the absence of ovaries. Ojeda et al. [6] . reported that Eap1 plays a dual role in transcriptional activities (it trans-activates secretion promoting genes while suppresses inhibitory genes of GnRH neuronal function). More recently, a mechanistic study demonstrated that Eap1 is recruited to the KiSS1 promoter, and paired immunofluorescence assays showed Eap1 and kisspeptin are co-expressed in neurons in the medial basal hypothalamus [7] . This suggests that Eap1 may transcriptionally regulate KiSS1 gene expression. Several studies demonstrate that Kisspeptin robustly stimulates the secretion of GnRH through the KiSS1/GPR54 signal pathway and plays a pivotal role in the initiation of puberty. Furthermore, KiSS1 neurons integrate several factors that influence Gnrh-neurons activation, these include nutritional status, environmental cues, and socioeconomic factors [8] .
In agressment with other studied, we previously demonstrated that the number of Eap1 immuno-positive cells in the hypothalamus peaked in early puberty but declined in adulthood [9] . Moreover, the Eap1-expressing neurons were proximally distributed around kiSS1 and GnRH expressing neurons. These data suggest that Eap1 may regulate the HPGaxis through stimulation of the kisspeptin/GPR54 signaling pathway. To test this hypothesis, we utilized RNAi to experimentally examine the consequences of rat hypothalamic Eap1 suppression in conjunction with observing key events associated with the onset of puberty, paralleled by specific detection of key regulators KiSS1 and GnRH.
Materials and Methods

Animals
Sprague-Dawley rats at 21 days of age were purchased from Shanghai SLAC Laboratory Animal Co. (Shanghai, China) and randomly divided into three groups: saline, lentivirus (LV)-enhanced green fluorescent protein (eGFP), and LV-Eap1-shRNA. Upon arrival, they were subjected to intracerebroventricular microinjections between hours 13:00 and 17:00. The rats were then housed under controlled temperature (21±2°C) and humidity (55±10%) conditions, with a 12h light/12h dark cycle (lights on at hours 7:00 -19: 00). Food and water were provided ad libitum. The animals were inspected for vaginal opening every afternoon between hours 16:00 and 17:00. Finally, the rats were euthanized at the juvenile, early puberty, and adult stages (PND25, PND35, and PND42, respectively) between hours 16:00 and 17:00. All experiments were approved by the Institutional Animal Care and Use Committee of Shanghai, China.
Cell culture NRK-52E, a kidney epithelial cell line (Cell Bank of the Chinese Academy of Sciences) which can express the EAP1 gene, was cultured in a humidified atmosphere containing 5% CO 2 and 37°C. The cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 5% fetal bovine serum (FBS, Gibco), 1.5 mM glutamine, 100 U/mL penicillin, and 100 µg/mL streptomycin. Table 1 . Each Eap1-shRNA sequence contained a 21-nt sense strand, a TTCAAGAGA-loop, and a 21-nt antisense strand. For the purpose of cloning, BamHI (GATCC) and EcoRI (AATTC) sequences were respectibely added to the 5ʹ and 3ʹ flanking regions. These oligonucleotide sequences were cloned into the LV3 vector (Gene-Pharma) through restriction enzyme-mediated digestion and ligation with T4 DNA ligase. The resulting constructs were then transfected into 293T cells after precipitation in calcium phosphate method [10] . This procedure was utilized to identify the Eap1 shRNA that led to optimal suppression.
Lentiviral (LV) particle production.
To engineer lentiviral (LV) particles, we adapted the RNAi-Mate (Gene-Pharma) protocol to co-transfect 293T cells with three packaging plasmids (pGag/Pol, pRev, and pVSV-G) with the described LV-shRNA vector. After 72h, the LV particles were collected, and the viral titer was determined after infecting separate 293T cells with serial dilutions of the viral stock, subsequent selection and determination of multiplicity of infection. The resulting virus was subsequently stored at -80°C.
NRK-52E cells were seeded in a six-well plate at a density of 4×10 4 cells/well in antibiotic-free DMEM for 24h. In parallel, they were next infected with tittered LV mixtures containing 1 of 4 shRNA against Eap1 (LV-Eap1-shRNA1-4) or control (LV-eGFP) as well as polybrene (5μg/mL). Total RNA and protein were separately extracted 72 and 96h post infection to deternime the magnitude of Eap1suppression.
Intracerebroventricular injections of LV particles
For intracerebronventricular injections, we adapted procedures from our previous study [11] . Briefly, 21-day-old rats were positioned in a stereotaxic instrument after they were deeply anesthetized with 1% sodium pentobarbital (0.5 mL/100 g body weight).The skin and periosteum were incised to expose the bregma point, and a microsyringe with 40μl LV-(-), LV-Eap1-shRNA1-4, or saline was inserted into the skull at a 90° angle (parameters: 0.8mm rostral from bregma, 1.5mm lateral from midline, and 3.5mm ventral from the surface of the skull). This was held for 5-10 min and then slowly injected at a speed of 4µl/min, and the syringe was retained for another 5-10 min before it was removed.
Tissue preparation
Rats were anesthetized with 1% sodium pentobarbital (0.5mL/100 g body weight), decapitated to collect the whole brain and subsequently frozen on dry ice. Brains were serially sectioned using a cryostat. Two hypothalamic regions (preoptic area/anteroventral periventricular nucleus (POA/AVPV) and (arcuate nucleus ARC)) were microdissected according to the anatomical landmarks by a stereo taxic coordinate atlas. The POA/AVPV (POA which contains GnRH neurons while AVPV consists of one of the two populations of KiSS1-expressing neurons) was cut into 100-μm section and dissected from six consecutive sections. The ARC (the other population of KiSS1-expressing neurons) was cut into 300-μm section and dissected from eight consecutive sections. The tissues were also used to assay for RNA or protein expression. Finally, the ovaries were also collected and weighed from the euthanized rats.
Hematoxylin and eosin (H&E) staining and quantification of corpous luteum (CL)
Ovaries were fixed in 4% paraformaldehyde at 4°C for 8 h. Subsequently they were dehydrated in a series of ethanol concentrations, cleared in xylene, embedded in paraffin, and serially sectioned at 6μm. Six representative sections were selected from each ovary; these were deparaffinized in xylene, hydrated 
Reverse transcription and quantitative polymerase chain reaction (qPCR)
Total RNA was extracted using the TRIzol reagent (Invitrogen, USA) according to the manufacturer's instructions. After the RNA was concentrated and purified 1µg of each sample was re verse-transcribed into cDNA, and qPCR was performed in a final mixture of 20 µL. The PCR conditions were as follows: initial denaturation at 95°C for 1 min. 40 cycles of denaturation at 95°C for 10 s, annealing at 60°C for 30 s, and extension at 72°C for 1 min. And a final extension step was included at 72°C for 7 min. Each qPCR reaction was performed in triplicate. The primers (Table 2) were synthesized by Shanghai Sangon Biotech Co., Ltd., and β-actin primers were used as the internal control.
Western blotting
Cell or hypothalamus tissue samples were homogenized in lysis buffer (Thermo Fisher, USA) containing a protease inhibitor cocktail. The supernatant was collected after centrifugation at 14, 000 rpm for 15min at 4°C, and the protein concentration was determined using the bicin choninic acid (BCA) assay kit. Protein samples were separated using 10% or 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE ) (for Eap1 and kisspeptin, respectively), and then transferred onto nitrocellulose (NC) membranes. The membranes were blocked with 5% nonfat milk for 1 h at 4°C, incubated with anti-Eap1 (1:500, Sigma-Aldrich), or anti-kisspeptin(1:500, Cell Signaling Technologies) antibodies at 4°C overnight, or anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody (1:1000, Cell Signaling Technologies) at 4°C for 2h. Subsequently, the membranes were rinsed three times with Tris-buffered saline with Tween (TBST) every 5-10 min, and probed with secondary antibody (1:10000, HRP labeled, Jackson, U.S.A.) at 24°C for 1h. After three additional rinses with TBS, the membranes were developed using an enhanced chemiluminescence (ECL) reagent.
Statistical analysis
The Statistical Package for the Social Sciences (SPSS) version 13.0 statistical software was used for the analysis. The data were expressed as mean ± standard deviation (SD) and the significance of the differences between groups was analyzed using one-way analysis of variance (ANOVA). The level of significance was p <0.05.
Results
Engineering and optimization of Eap1 suppression in cells
We fist sought to engineer a model that permits clear detection of Eap1 suppression in tissue. LV3 backbones containing eGFP driven by a separate CMV promoter were used to engineer shRNA constructs as indicated in Fig. 1A , and the sequencing results authenticated each cloned contruct (Fig. 1B, LV-shRNA4 is shown as an example). We also optimized lentivirus (LV) titer. Specifically, the viral stock solution was serially diluted to obtain four concentrations 10-fold apart, and these were subsequently used to infect 293T cells. Based on the population of GFP-fluorescent cells, the titer of the LV-shRNA was calculated at 3.8 ×10 8 TU/mL (Fig. 1C) . 
To determine the relative efficacy of Eap1 suppression, NRK-52E cells were in parallel transfected with LV-Eap1-shRNAs or LV-eGFP. Eap1 mRNA and protein levels were measured 72 and 96 hours post transfection. As shown in Fig. 2A and B, infection with LV-Eap1-shRNAs reduced EAP1 transcripts, and relative to LV-eGFP, shRNA1-4 suppressed expression at 99.4, 95.7, 93.8, and 99.7% at 72h while at 82.5, 97.5, 17.6, and 98.7% at 96h, (Fig. 2 A and B) . We further confirm relative suppression of Eap1 protein expression through western blots ( Fig.  2C and D) . In summary, we engineered a GFP co-expressing lentiviral construct (LV-shRNA4) that effectively suppresses Eap1 for the use in subsequent experiments.
In vivo suppression of Eap1 in rat bypothalamus via intracerebroventricular injection
After intracerebroventricular injection of the respective LV, we next confirmed LV particles penetrated the lateral ventricle to the third ventricle and infected proximal cells. To do so, we used confocal microscopy to detect GFP fluorescence. We observed that cells around the third ventricle (kiSS1-expressing neurons are mainly distributed in AVPV and ARC which is a thin cell layer around third ventricle) were GFP positive (Fig. 3) . We next examined the efficacy Eap1 suppression in two hypothalamic regions. Rats microinjected with either LV-Eap1-shRNA, LV-eGFP or saline groups were euthanized at the three sexual developmental stages. As expected, RNAi of Eap1 reduced mRNA levels in the LV-Eap1-shRNA injected mice relative to the saline or LV-eGFP injected groups at each of the three developmental stages in the POA/AVPV (Fig. 4 A) . We did not observe differences in EAP1 expression amongst the saline and LV-eGFP group as their differences were not significant (P >0.05). Additionally, the Eap1 protein expression was consistent with mRNA expression. Specifically, we observed reduced Eap1 protein expression upon LV-Eap1-shRNA microinjection relative to saline or LV-eGFP injected groups at all three developmental ages in the AVPV (Fig. 4C) . Eap1 protein expression was not perturbed in each control microinjection group. In the ARC, we did not obserbe relative suppression of Eap1 protein or mRNA expression between any of different ages groups (Fig. 4B.D.) . These results indicate we successfully suppressed Eap1 in rat POA/AVPV, allowing subsequent examination of Eap1 fuctions in the POA/AVPV.
Eap1 suppression delays vaginal opening and perturbs ovary development.
Eap1 regulates the onset of puberty and the reproductive cycle. We next examined vaginal opening every afternoon from hours 16:00 to 17:00h after the intracerebroventricular injection of LV-Eap1-shRNA. As shown in Fig. 5A , the average time of vaginal open ing in the LV-Eap1-shRNA group was significantly delayed compared with that of the saline or LV-eGFP groups. Cinfirming Eap1 POA/AVPV expression as a key component for sexual development. Furthermore, we used H&E staining to observe the ovarian morphology and function (Fig.  5C ). At PND35, CL numbers were lower in the LV-Eap1-shRNA group relative to other developmental stages. However, there appeared to be no difference among groups at PND42 (Fig. 5D) . Additionally, we also observe that the ovarian index (ovary weight/body weight) at PND35 was lower in EAP1 suppressed group relative to other groups, and no changes were observed at other developmental stages (Table 3) .
Hypothalamic GnRH and KiSS1 expression are didderentially regulated by Eap1 suppression
GnRH, predominantly found in rat POA, integrates critical neuroendocrine signals for hypothalamic regulation of puberty and its expression reflects the activation of the HPG axis. To determine its regulation by Eap1, upon collecting total mRNA from POA/AVPV, we exam- 
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Cellular Physiology and Biochemistry ined relative GnRH transcript levels with qPCR, We noticed that GnRH was reduced in LVEap1-shRNA injected relative to control groups at the juvenile (PND25) and early puberty stages (PND35). However, we obserbed no difference amongst treatment groups at the adult stage (PND42) (Fig. 5B) . Our results that associate GnRH regulation to Eap1coincided with phenotypic observations regarding vaginal opening and ovarian index. Studies have demonstrated that KiSS1 regulates secretion of GnRH. As a key focus, we aimed to determine whether the control of puberty by Eap1 is mediated through KiSS1. In Eap1 suppressed samples, we determined the overall expression of hypothalamic KiSS1 with qPCR and western blots. Despote changes in GnRH, which is a perceived KiSS1 transcripts were not significantly different amongst groups at each developmental stage (Fig. 6A, B , and C). We also did not observe differences in KiSS1 protein expression (Fig. 6E, F, and G) . Overall, our results indicate that Eap1 regulated puberty through GnRH without affecting KiSS1.
Discussion
The loss of Eap1 expression in the medial basal hypothalamus (MBH) of the nonhuman primate hypothalamus abrogates the menstrual cycle [12] . Additionally, Lomniczi et al. [13] . report a single nucleotide polymorphism of the Eap1 gene was associated with amenorrhea or oligomenorrhea in rhesus macaques. These observations demonstrate that Eap1 acts as a key developmental regulator of the female reproduction system in both rodents and nonhuman primates. In this study, we successfully engineered a lentiviral construct and . In the early puberty group, the ovarian index of the LV-shRNA group was significantly lower compared to the indices of the saline and LV (-) groups. *, P < 0.05; (n=8) further optimized conditions to specifically suppress Eap1 in POA/AVPV via intraventricular microinjection [11, 14] . Eap1 suppression delayed onset of puberty. This observation was accompanied by a decline in ovarian function, as reflected by CL formation, during earlystage puberty. Our findings are consistent with previous studies [4] . Furthermore, we also note that Eap1 suppression in the POA/AVPV led to a decrease in hypothalamic GnRH content, which reflected the observed phenotypic defects. Surprisingly, both mRNA and protein expression of the KiSS1 gene in the AVPV were unchanged by Eap1 suppression, which diffeers from our preceding hypothesis In which Eap1 regulates the secretion of GnRH through KiSS1/GPR54 signaling. Eap1 is an intronless gene located on chromosome 14q24.3 [15] . Reports agree that it acts upstream of the hypothalamic network that regulates reproductive development and functions. Eap1 contains an N-terminal C4 zinc finger and a C-terminal RING finger domain [16] . The RING finger-containing domain is predicted to participate in proteinprotein interaction and ubiquitination, while the zinc finger domain was hypothesized to be involved in the transcriptional modification of DNA or RNA [17, 18] . Previous studies have demonstrated that Eap1 transactivates the GnRH promoter but represses the preproenkephalin promoter, inferring that it has a dual transcriptional activity [4] . In 2012, Mueller et al. [19] . discovered that Eap1 was regulated by ttf1, cux1, and yy1. These are upstream components of the Tumor-related gene (TRG) network that also regulate puberty. In Hela cells, Muller et al. [7] . utilized ChIP assays to demonstrate interactions between Eap1 and KiSS1 promoter; this in turn led to repression of KiSS1 expression in Grip-Tite™ 293 MSR cells and GT1-7 neurons. These observarions contradict our findings, and may result from differences in cell lineage or signaling context specific to each cell lines.
In our study, upon in vivo suppression Eap1, we observed no differences in KiSS1 expression, whereas GnRH expression was significantly reduced. Our findings indicate Eap1 signals through the HPG axis by direct regulation of GnRH neurons, which are primarily located in the POA [20] ; and this appears to involve pathways other than KiSS1/GPR54. A previous study identifies that Eap1 and GnRH are co-expressed in some neurons and Eap1 directly promotes GnRH expression in GT1-7 cells. This depicts a model in which Eap1 acts on GnRH neurons directly [4] . Nevertheless, our results also demonstrate that even upon Eap1 suppression, GnRH and ovarian function Are normal in adults. By visualizing eGFP-positive cells around the third ventricle, we estimate 60% of the AVPV/POA neurons were infected by the LV particles [21] and this sufficiently perturbed the onset of puberty. However, effects on puberty were temporal; as the GnRH expression levels eventually recovered. This implies that while Eap1 is important, other factors may also regulate female puberty development, and these genes ultimately amount to a compensatory response. Additionally, despite our findings, we still cannot entirely exclude the role of KiSS1/GPR54 signaling in Eap1-driven puberty. KiSS1 neurons consist of two populations (AVPV and ARC) and KiSS1 neurons may exert distinct biology in each context [22] . As an example, AVPV KiSS1 neurons display a positive feedback to estrogen signals while those of the ARC pertain a negative feedback effect. While we did not observe Eap1 regulation of KiSS1 expression in AVPV, it remains a possibility that it regulates KiSS1 in ARC, in which additional studies are required are necessary to examine this potential regulation.
In temporally controlled fashion, puberty inhibitory genes are predominantly expressed, while these are reduced during the onset of puberty. On the other hand, expression of excitatory genes such as KiSS1, Tac are elevated and initiate sexual maturation [23] . Abreu et al. [24] [25] [26] . reported that a loss-of-function mutation of makorin ring finger protein 3 (MKRN3) is a common cause of familial central precocious puberty; this implicates that MKRN3 as a key repressor of puberty control as well as a new pathway of puberty regulation. The discovery of MKRN3 emphasizes the importance of inhibitory signals in the reproductive signaling axis, and that suppression of MKRN3 may also be a required for the initiation of puberty. More recently, Eap1 was shown to be a component of the transcription-repressing complex, also known as interferon regulating factor-2 binding proteins; this inhibits the expression of downstream genes [27] . In conjunction with previous findings in which Eap1 Currently, epidemiological studies indicate that the incidence of precocious puberty in girls has rapidly increased in recent years [28] . Precocious puberty is associated with short adult height, increased breast cancer risk, polycystic ovarian syndrome, reproductive system neoplasms and metabolic syndrome [29] . Improving our understanding of underlying mechanisms that regulate maturation of reproductive systems will contribute to effective strategies in the prevention or treatment of precocious puberty.
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